Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global low-temperature sterilization equipment market was valued at US$ 1,120.1 million in 2016 and is expected to exhibit a CAGR of 10.6% over the forecast period (2017-2025).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1321
The global low-temperature sterilization equipment market is projected to observe considerable growth, buoyed by the increasing incidence of surgical procedures and popularity of minimally invasive surgical procedures worldwide. According to the American Society of Plastic Surgeons 2016, over 17.1 million minimally invasive surgical procedures were performed in the U.S. for various treatments.
The development of innovative sterilization techniques is anticipated to accelerate the growth of the global low temperature sterilization equipment market over the projected timeframe. Reprocessing and reusing of instruments before performing a surgical procedure is a pre requisite. However, inability of various surgical components to withstand high temperature during sterilization procedure can be resolved with the introduction of novel platforms and equipment that can perform sterilization of these components at low temperatures.
In April 2016, Becton Dickinson and Company introduced low temperature rigid sterilization container system that has a visually differentiated set for sterilization of various equipment to provide long lasting protection and sterility maintenance during surgical procedures. Furthermore, in 2013, Sterrad 100nx system was introduced by Advanced Sterilization Products (ASP). The product features enhanced efficiency in sterilizing the single channel flexible scopes and accessory light cords together as a set and cameras. Low-temperature sterilization techniques are increasingly being developed worldwide for minimally invasive surgical instruments, and other non-heat tolerant hospital equipment.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1321
The glutaraldehyde advanced sterilization products that were used conventionally for low-temperature sterilization procedures are now replaced with new technologies, such as ethylene oxide, vaporized oxygen peroxide and others. These techniques are highly effective even against superbugs that are microbes with developed resistance against a vast number of antibiotics. As reported by the Centers for Disease Control and Prevention (CDC) 2013, the superbugs led to around 50% of deaths owing to the use of disinfected or non-sterile instruments.
- Surging incidence of minimally invasive surgical procedures and increasing prevalence of healthcare-associated infections across the globe are pivotal factors spurring the global market growth.
- The ethylene oxide sterilization technology segment leads the global low-temperature sterilization equipment market, as this is a standard test for sterilization of plastics and other low-temperature tolerant equipment.
- The hospital’s end-user segment emerged as the leading segment in the global low-temperature sterilization procedures as most of the surgical procedures that require advanced instruments are performed in hospitals.
- North America is expected to dominate the global low-temperature sterilization equipment market, owing to the major presence of leading companies making R&D investments for innovative devices.
Browse Press Release: https://bit.ly/2EMeZvQ
The key companies operating in the global low-temperature sterilization equipment market include 3M Company, Steris Corporation, Belimed AG, Cantel Medical Corporation, Anderson products, Advanced Sterilization Products, Matachana Group, Sterigenics International, and MMM Group.
These players are focused on extensive R&D of efficient sterilization systems. For instance, in January 2017, Advanced Sterilization Products (ASP) introduced next-generation low-temperature sterilization equipment, called STERRAD 100NX system, integrated with the ALLClear technology, is a simplified system operation that automatically monitors the conditions to minimize workflow interruptions and cycle cancellations. Furthermore, in August 2017, 3M received FDA approval forrapid sterilization test kit that enables low-temperature sterilization using vaporized hydrogen peroxide in 24 minutes cycle that usually takes about 4 hours to complete.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1321
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027